News Novartis' canakinumab cuts risk for heart attack survivors Novartis to discuss canakinumab results with regulators.
News MSD and Bayer launch big gamble on heart failure candidate Aims to recruit 4,900 patients to prove value in heart failure
News Medtronic to buy HeartWare, expand heart failure portfolio Deal worth an estimated $1.1 billion.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
